In our biomarker-defined subpopulation, we observed a 0.27 effect size on the EMACC cognitive scale after only 6 months (2). For directional context, this magnitude compares favorably to the 18-month ...
Researchers at the new Center for Brain Health at UT Health San Antonio are studying midlife testing for early-onset dementia with blood-based biomarkers to see if they can detect disease activity up ...
INmune Bio, Inc. (NASDAQ: INMB), a clinical-stage inflammation and immunology company, presents the following letter to investors from David Moss, CEO: ...
From Adelaide to San Francisco, the biotechnology landscape is shifting – and, in some cases, straining under the weight of ...
The pharmaceutical sector continues to evolve at an unprecedented pace. In this dynamic environment, where hundreds of ...
Discusses Quarterly Activity, Cash Flow Update, and Progress of Sofdra for Hyperhidrosis January 26, 2026 7:30 ...
DelveInsight provides structured pharma conference coverage solutions designed to help industry leaders to track and interpret critical developments emerging from major healthcare conferences.
Discusses 3-Year Topline Results From EMBARK Phase 3 Trial of ELEVIDYS in Duchenne Muscular Dystrophy January 26, ...
Gov. Josh Green will deliver his fourth State of the State address today to the Hawaii State Legislature at the Hawaii State ...
Johnson & Johnson (NYSE:JNJ) Q4 2025 Earnings Call Transcript January 21, 2026 Johnson & Johnson reports earnings inline with ...
At the beginning of 2025, the American Heart Association released its annual statistics on heart disease, which sadly remains ...
A great ride starts long before you start pedaling. These 10 simple habits—fitness checks, time buffers, smart navigation, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results